Pilot Study to Determine the Optimal Negative Pressure for Non-invasive Breast Augmentation in Women

Breast Hypoplasia Clinical Trial

Official title: A Double-blind Pilot Study to Determine the Optimal Negative Pressure of EVERA-RAPHA for Non-invasive Breast Augmentation in Women

Status Completed

Clinical Trial Summary

Aim is to investigate optimum pressure and evaluate safety and effectiveness of EVERA-RAPHA for breast augmentation

Clinical Trial Description

1. Subjects who voluntarily signed a consent form and met all inclusion / exclusion criteria should enroll in this study.

2. Subjects enrolled in the study will be randomized and assigned to either Group1 or Group2 in a 1: 1 ratio.

3. Apply EVERA RAPHA for 4 weeks

3. Measure breast circumference and breast volume at Baseline and 4weeks later 4. Visit after 4 weeks to evaluate safety and effectiveness ;

Related Conditions & MeSH terms

• Breast Hypoplasia

• NCT number: NCT04185961
• Study type: Interventional
• Source: Seoul National University Hospital
• Status: Completed
• Phase: N/A
• Start date: January 6, 2020
• Completion date: April 6, 2020